IC
KZR

Ikarian Capital’s Kezar Life Sciences KZR Stock Holding History

Ikarian Capital’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-107,530
Closed -$8.89M – 139
2022
Q2 		$8.89M Buy
107,530
+79,450
+283% +$7.01M 1.62% 20
2022
Q1 		$4.67M Buy
28,080
+11,150
+66% +$1.6M 0.61% 45
2021
Q4 		$2.83M Buy
+16,930
New +$1.91M 0.42% 52

Ikarian Capital's KZR Position: Q2 2026 in Review

Ikarian Capital sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 102,211 shares — an estimated $758K sold.

Ikarian Capital first reported a position in KZR in Q4 2021 and held it in 18 quarters. The position peaked at $18M in Q1 2022. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • Ikarian Capital reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Ikarian Capital sold 102,211 Kezar Life Sciences shares in Q2 2026, an estimated $758K.
  • Ikarian Capital first reported a position in Kezar Life Sciences in Q4 2021 and held it in 18 quarters.
  • Ikarian Capital's Kezar Life Sciences position peaked at $18M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.